CHNA

Fund Description
The Loncar China BioPharma ETF trades on Nasdaq under the symbol CHNA. It is made of up a basket of companies that are leading China s biotech revolution. With a focus on innovators, the fund contains globally listed pharmaceutical companies, biotech companies, drug manufacturers, diagnostics companies, wholesalers, distributors and service providers that have a strategic role in growing China s drug industry. CHNA ETF offers this global exposure all in the convenience of one security that trades in the United States. It tracks the LCHINA index.
Fund Profile
Fund Name Loncar China Biopharma ETF
Fund Exchange Ticker CHNA
Fund Sponsor Exchange Traded Concepts
Fund ISIN US26922A3703
Net Expense Ratio 0.79 %
Fund Inception Date 14 August 2018
Fund Legal Structure ETF (Open end fund)
Exchange NASDAQ
Listing Country Code US
Fund Investment Objective
ETF Type Specific Global or ExUS Equities - Industry Sector
Asset Class Equities (Stocks)
Index Linked Passive
Index Name Loncar China BioPharma Index
Index Provider Loncar Investments
Currency Hedged No
Inverse / Leveraged Not Applicable
Developed / Emerging Emerging Market Funds
Market Capitalization Range Broad Market / Multi-Cap
Growth Value Core / Blend
Continent Asia
Key Statistics
Return As of Date 14 June 2019
Asset Under Management 3.19 Million (USD)
1 Month Total Return -3.71 %
Year To Date Return 10.82 %
1 Year Total Return
3 Year Annualized Total Return
NAV 21.2861
Share Outstanding 150,000
Top 10 Holdings (14 June 2019)
Constituent Name Constituent Ticker Constituent Type Weighting
GENSCRIPT BIOTECH CORP 1548 EQUI 0.0544000000
WUXI APPTEC CO LTD-H 2359 EQUI 0.0530000000
SHANGHAI JUNSHI BIOSCIENCE-H 1877 EQUI 0.0449000000
INNOVENT BIOLOGICS INC 1801 EQUI 0.0420000000
CSPC PHARMACEUTICAL GROUP LT 1093 EQUI 0.0412000000
CHINA BIOLOGIC PRODS HLDGS INC COM CBPO EQUI 0.0403000000
HUTCHISON CHINA MEDITECH-ADR HCM EQUI 0.0399000000
YICHANG HEC CHANGJIANG PHA-H 1558 EQUI 0.0382000000
SINOPHARM GROUP CO-H 1099 EQUI 0.0371000000
GUANGZHOU BAIYUNSHAN PHARM-H 874 EQUI 0.0368000000